Breast Cancer Phenotype in Women With TP53 Germline Mutations: A Li-Fraumeni Syndrome Consortium Effort

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-012-1993-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cancer Phenotype Correlates With Constitutional TP53 Genotype in Families With the Li–Fraumeni Syndrome

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

A Novel HER2-positive Breast Cancer Phenotype Arising From Germline TP53 Mutations

Journal of Medical Genetics
Genetics
2010English

TP53 (Tumour Protein P53 (Li-Fraumeni Syndrome))

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Germline TP53 and MSH6 Mutations Implicated in Sporadic Triple-Negative Breast Cancer (TNBC): A Preliminary Study

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

P53 Therapy in a Patient With Li-Fraumeni Syndrome

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Radiation-Induced G1 Arrest Is Not Defective in Fibroblasts From Li-Fraumeni Families Without TP53 Mutations

British Journal of Cancer
Cancer ResearchOncology
1999English

Li-Fraumeni Syndrome: A P53 Family Affair

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2005English

Li‐Fraumeni Versus Pseudo‐Li‐Fraumeni Syndrome: Key Insights for Interpreting Next‐Generation Sequencing Reports in Patients With Suspected Cancer Predisposition Syndromes

Oncologist
Cancer ResearchMedicineOncology
2017English

TP53 Mutations Promote Immunogenic Activity in Breast Cancer

Journal of Oncology
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy